Molecular genetic markers of breast cancer

Molecular genetic markers of breast cancer

Breast cancer (BC) is the second most common type of cancer worldwide and affects 1 in 8 women over the course of their lifetime. A personalized approach to treating BC can substantially increase efficiency and consequently maintain the active life of many people. This encourages investigators and p...

Full description

Bibliographic Details
Main Authors:	K. A. Grishina, T. A. Muzaffarova, V. A. Khaylenko, A. V. Karpukhin
Format:	Article
Language:	Russian
Published:	ABV-press 2016-11-01
Series:	Опухоли женской репродуктивной системы
Subjects:	рак молочной железы молекулярная классификация экспрессионные подтипы современные прогностические системы мутации
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/506

Similar Items

Subtypes of breast cancer
by: D. D. Pak, et al.
Published: (2014-07-01)

PREDICTORS OF A LOCAL RECURRENCE AFTER ORGAN-PRESERVING TREATMENT FOR EARLY BREAST CANCER: STATE-OF-THE-ART
by: N. R. Molodikova, et al.
Published: (2014-09-01)

Choice of adjuvant drug therapy on the basis of the molecular classification of breast cancer
by: N. S. Besova
Published: (2014-07-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Role of microRNAs in breast cancer development and their potential as biomarkers
by: K. A. Grishina, et al.
Published: (2018-10-01)

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
by: Yu. S. Krumin, et al.
Published: (2021-03-01)

The role of biomarkers in the early diagnostics of breast cancer
by: A. Kh. Ismagilov, et al.
Published: (2021-03-01)

Comparative analysis of the long-term results of treatment in patients with Stages I-IIa breast cancer in relation to major prognostic factors
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

BREAST CANCER TYPING USING RT-PCR ASSAY
by: V. K. Bozhenko, et al.
Published: (2019-11-01)

ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer
by: V. O. Tarakanova, et al.
Published: (2022-06-01)

Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM)
by: A. A. Bozhok, et al.
Published: (2017-02-01)

Current molecular genetic markers of breast cancer
by: N. V. Apanovich, et al.
Published: (2014-07-01)

New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
by: P. A. Gervas, et al.
Published: (2022-01-01)

Breast conserving surgery in the treatment of breast cancer stage III
by: D. V. Khaylenko, et al.
Published: (2016-06-01)

Intratumoural Effector Cell Subpopulations in Breast Cancer: a Literature Review and Own Data Report
by: D. A. Ryabchikov, et al.
Published: (2021-12-01)

Breast cancer risk factors assessment and BRCA-associated breast cancer evaluation in mammographic screening in India
by: S. K. Ternovoy, et al.
Published: (2014-07-01)

Ethnic aspects of hereditary breast cancer
by: P. A. Gervas, et al.
Published: (2019-04-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

Problems in the treatment of dyshormonal breast hyperplasia: current aspects
by: E. A. Sukhareva, et al.
Published: (2014-08-01)

X-ray and ultrasound semiotics of mucinous carcinoma of the breast
by: K. A. Lesko, et al.
Published: (2014-07-01)

Proteomic studies searching for breast cancer markers: а review of literature
by: M. A. Taipov, et al.
Published: (2015-07-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
by: K. B. Kotiv, et al.
Published: (2017-12-01)

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery
by: L. N. Lyubchenko, et al.
Published: (2015-06-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

PROTEASOMAL AND CALPAIN PROTEOLYSIS SYSTEMS IN DIFFERENT MOLECULAR SUBTYPES OF BREAST CANCER
by: E. E. Shashova, et al.
Published: (2017-07-01)

The role of digital mammography, scintimammography with <sup>99m </sup>Tc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer
by: A. V. Chernaya, et al.
Published: (2020-03-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER
by: N. V. Krakhmal, et al.
Published: (2016-10-01)

Studying of the effect of the genetic variant c.470T>C in the CHEK2 gene on increasing the risk of breast cancer in the population of the Russian Federation
by: E. I. Novikova, et al.
Published: (2021-05-01)

THE LONG-TERM RESULTS OF OCCULT BREAST CARCINOMA TREATMENT
by: T. V. Kuklenko
Published: (2017-01-01)

Blood coagulation system state in breast cancer patients that recovered from coronaviral infection after undergoing antitumor medical treatment
by: L. Yu. Vladimirova, et al.
Published: (2022-09-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

Occult breast cancer. Literature review and case series
by: О. S. Khodorovich, et al.
Published: (2021-03-01)

Strategy of post-neoadjuvant treatment of patients with residual breast cancer
by: V. V. Semiglazov, et al.
Published: (2020-06-01)

SURGICAL TREATMENT OF BREAST CANCER: FROM THE CONCEPT OF ERADICATION TO AESTHETIC SURGERY
by: I. K. Vorotnikov, et al.
Published: (2018-08-01)

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer
by: A. F. Nasretdinov, et al.
Published: (2020-06-01)

Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study
by: L. A. Tashireva, et al.
Published: (2022-01-01)

Paget’s disease of the breast (a review of literature)
by: E. A. Nikitina, et al.
Published: (2017-02-01)

The current results of the Breast Cancer Screening Program in the State Clinical Hospital of Khanty-Mansiysk
by: N. A. Zakharova, et al.
Published: (2014-08-01)